RxDoctor Payments Data

James Greer, DPM

Podiatrist · Brentwood, CANPI 1376632596

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (47.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 42.0% of the total. Reporting peaked in 2023 at $3,276 and has fallen 60.2% since, to $1,305 in 2025. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,101in general payments, 2019–2025

Across 117 payments — averaging $86.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$4K
  • Arthrosurface Incorporated$2K
  • Paragon 28, Inc.$1K
  • Arthrex$1K
  • Smith+Nephew$1K
  • DJO, LLC$224
  • plus $337 from 12 others

What the payments were for

  • Travel & lodging$4,83548%
  • Food & beverage$3,80838%
  • Education$1,45914%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,101 in reported general payments places this provider in the 90th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California

Medicare billing

Part B allowed, 2024
$645,359
Medicare patients
426
Services billed
6,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl113$921
Cephalexin36$675
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip18$334
Gabapentin35$272
Allopurinol32$248
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$207
CiclopiroxCiclopirox Olamine11$201
Duloxetine Hcl26$199
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$146
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$48

Paid to pharmacies, not to this prescriber.

Other podiatrist in Brentwood

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →